No Data
No Data
ADC Therapeutics Stock Plunges 36% Amid Zynlonta Data Release
Xaira Therapeutics Announces the Appointment of Dr. Paulo Fontoura as Chief Medical Officer and Dr. Hetu Kamisetty as Chief Technology Officer
Reported Earlier, Roche's Genentech Presents Long-Term Data at ASH 2024 Highlighting Durable Remissions With Fixed-Duration Columvi And Lunsumio
Biogen Downgraded to Hold by Jefferies, Ocrevus Royalties Cited
Reported Sunday, Roche's Genentech Showcases Polivy's Transformative Impact On Frontline DLBCL Treatment: Five-Year POLARIX Trial Results Presented At ASH 2024
Kepler Capital Sticks to Their Buy Rating for Roche Holding AG (RHHVF)
No Data